A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

Paclitaxel and capecitabine, which have distinct mechanisms of action and toxicity profiles, have each shown high activity as single agents in gastric cancer. Synergistic interaction between these two drugs was suggested by taxane-induced upregulation of thymidine phosphorylase. We, therefore, evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, H J, Chang, H M, Kim, T W, Ryu, M-H, Sohn, H-J, Yook, J H, Oh, S T, Kim, B S, Lee, J-S, Kang, Y-K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361449/
https://www.ncbi.nlm.nih.gov/pubmed/18219288
http://dx.doi.org/10.1038/sj.bjc.6604186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361449/
https://www.ncbi.nlm.nih.gov/pubmed/18219288
http://dx.doi.org/10.1038/sj.bjc.6604186

Ejemplares similares